SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-048755
Filing Date
2023-09-08
Accepted
2023-09-08 16:00:17
Documents
1
Period of Report
2023-09-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5450
  Complete submission text file 0001209191-23-048755.txt   6837
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Issuer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SURFACE ONCOLOGY 50 HAMPSHIRE ST., 8TH FLOOR CAMBRIDGE MA 02139
Business Address
GRAYZEL DAVID S. (Reporting) CIK: 0001732786 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38459 | Film No.: 231245226